Key result
A progressive shift from isoflurane to more expensive agents (sevoflurane and desflurane) over 11 years increased cumulative expenditure by 168%.
Population
Tertiary level hospital assessing inhalational anaesthetic agent expenditure over 11 years (1997-2007)
Design
Other
Follow-up
11 years (1997-2007)
Authors
Loading...
May warrant review of inhalational agent selection to contain costs; leaves open whether outcomes justify the shift.
Observational
No
There was a progressive shift toward more expensive inhalational anaesthetic agents over 11 years, leading to a 168% increase in costs that significantly outpaced patient workload increases.
Weinberg et al. (2010) conducted an observational in Anaesthesia. Volatile inhalational anaesthetic agents was evaluated on Cumulative drug expenditure. A progressive shift from isoflurane to more expensive agents (sevoflurane and desflurane) over 11 years increased cumulative expenditure by 168%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: